NEW YORK (TheStreet) -- Shares of Monsanto (MON) were rising in mid-afternoon trading on Monday ahead of the seed and chemical producer's fiscal 2016 fourth quarter financial report, due out before Wednesday's market open.

Analysts surveyed by Thomson Reuters are looking for St. Louis-based Monsanto to post a loss of two cents per share on revenue of $2.36 billion.

In 2015, Monsanto reported a loss of 19 cents per share on revenue of $2.35 billion for the same period.

The company recently accepted a $66 billion all-cash takeover offer from German chemical and drug maker Bayer (BAYRY).

The proposed transaction will likely face both political and regulatory scrutiny as the combined company would become the largest seed and pesticide maker in the world, Reuters reported.

Senator Bernie Sanders (I-VT) has said that the deal is a "threat to all Americans," according to Reuters.

The companies expect the deal to close by the end of 2017.

Separately, TheStreet Ratings objectively rated Monsanto stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

TheStreet Ratings rated this stock as a "hold" with a ratings score of C+.

The company's strengths can be seen in multiple areas, such as its good cash flow from operations, expanding profit margins and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and generally higher debt management risk.

You can view the full analysis from the report here: MON